American journal of surgery · 2024
Results of a novel intervention to increase rates of diagnosis and treatment of primary hyperparathyroidism.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Lunardi Nicole, Meier Jennie, Stevens Audrey, Milburn Joseph, Oo Yin, Hathiramani Sumitha, Soe Kyaw, Balentine Courtney
Аннотация
BACKGROUND: Veterans with primary hyperparathyroidism are under diagnosed and undertreated. We report the results of a pilot study to address this problem.
METHODS: We implemented a stakeholder-driven, multi-component intervention to increase rates of diagnosis and treatment for primary hyperparathyroidism at a single VA hospital. Intervention effects were evaluated using an interrupted time series analysis.
RESULTS: The mean age of Veterans affected by the intervention was 67 years (SD 12.1) and 84 % were men. Compared to the pre-intervention period, the intervention doubled the proportion of Veterans who were appropriately evaluated for hyperparathyroidism (absolute difference 25 %, 95 % CI 11 %-38 %, p < 0.001) and increased referrals for treatment by 27 % (95 % CI 7 %-47 %, p < 0.012).
CONCLUSION: Our pilot study suggests it is feasible to address the underdiagnosis and undertreatment of primary hyperparathyroidism among Veterans.
METHODS: We implemented a stakeholder-driven, multi-component intervention to increase rates of diagnosis and treatment for primary hyperparathyroidism at a single VA hospital. Intervention effects were evaluated using an interrupted time series analysis.
RESULTS: The mean age of Veterans affected by the intervention was 67 years (SD 12.1) and 84 % were men. Compared to the pre-intervention period, the intervention doubled the proportion of Veterans who were appropriately evaluated for hyperparathyroidism (absolute difference 25 %, 95 % CI 11 %-38 %, p < 0.001) and increased referrals for treatment by 27 % (95 % CI 7 %-47 %, p < 0.012).
CONCLUSION: Our pilot study suggests it is feasible to address the underdiagnosis and undertreatment of primary hyperparathyroidism among Veterans.